🇺🇸 FDA
Patent

US 8609367

Genes and proteins for the biosynthesis of the lantibiotic 107891

granted A61PA61P31/04

Quick answer

US patent 8609367 (Genes and proteins for the biosynthesis of the lantibiotic 107891) held by Sentinella Pharmaceuticals, Inc. expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sentinella Pharmaceuticals, Inc.
Grant date
Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P31/04